Exhibitions and events
List of headings :
With pleasure we announce Oncomedics participation in the 5th plenary meeting that will take place in the Village club of Carry-le-Rouët, near Marseille, from Monday 25th to Wednesday 27th of November 2024.
 |
We are delighted to announce that Oncomedics is sponsoring the PINK 1 pathway to Parkinson's disease: 20 years on commemorate, that's taking place in the Mary Ward House, London England, on the 26th and 27th November 2024.
|
We are honored to annouce that Clinisciences is participating in the CARREFOUR PATHOLOGY 2024, that taking place in the CNIT Forest in Paris la Défense, from November 20 to 22nd 2024.
|
We are eager to announce that Oncomedics in sponsoring the Engineering Recombinant Proteins for Structural and Functional Studies 2024, a 2 days training that's going to take place in Motorpoint Arena Nottingham, on the 12th and 13th of November 2024.
|
- Date : From 18th to 19th June 2024 -
- Location : Hotel en Congrescentrum Heerlickheijd van Ermelo Staringlaan 1, 3852 LA Ermelo -
- Ermelo- Netherland -
|
Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.
|
We are pleased to announce that Oncomedics is sponsoring the National meeting of PhD Students in Neuroscience “Minds matter: creating connections in neuroscience research” will take place at the Centro Congressi “Federico II” in Naples on November 12th, 2024.
|
It is with great excitement that we share the news of Oncomedics' sponsorship of The scientific day of the Structure Fédérative de Recherche (SFR) Health Lyon East, Mark your calendars for November 19, 2024, as we gather at the Laennec Building of Claude Bernard University in Lyon.
|
We are pleased to announce that Oncomedics is sponsoring the event titled the Journey into the depths of the epidermis, which will take place at the Business & Learning Center at the University of Namur, Belgium, on November 22nd, 2024."
|
Oncomedics Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.
|